trapidil has been researched along with Psoriasis in 1 studies
Trapidil: A coronary vasodilator agent.
Psoriasis: A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Meffert, H | 1 |
| Rowe, E | 1 |
| Sönnichsen, N | 1 |
| Wischnewsky, GG | 1 |
1 other study available for trapidil and Psoriasis
| Article | Year |
|---|---|
[Trapidil in the treatment of chronic stable psoriasis].
Topics: Administration, Oral; Adult; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Psoria | 1988 |